
    
      A Randomized, Double-blinded, Double-dummy, Parallel-controlled and Multicenter Clinical
      trial to Investigate Blonanserin in Treatment of Schizophrenia when compared with Risperidone

      Trial drugs:

        -  Blonanserin group: Blonanserin tablets+Risperidone mimetic tablets

        -  Risperidone group: Risperidone tablets+Blonanserin mimetic tablets

      Objectives of Study :

      To evaluate the efficacy and safety of Blonanserin in treating schizophrenia
    
  